Humani papilomavirus kao potencijalni čimbenik rizika za oralne premaligne lezije by Lindita Zendeli-Bedjeti et al.
Acta Clin Croat 2017; 56:369-374 Original Scientiﬁ c Paper
10.20471/acc.2017.56.03.02
Acta Clin Croat, Vol. 56, No. 3, 2017  369
HUMAN PAPILLOMAVIRUS 
AS A POTENTIAL RISK FACTOR 
FOR ORAL PREMALIGNANT LESIONS
Lindita Zendeli-Bedjeti1, Mirjana Popovska1,2, Aneta Atanasovska-Stojanovska1,2 and Sotirija Duvlis3
1Department of Oral Pathology and Periodontology, St. Panteleimon University Dental Clinical Centre; 
2School of Dental Medicine; 3Institute of Public Health, Skopje, Republic of Macedonia
SUMMARY – Oral premalignant lesions (OPLs) and numerous alterations of oral mucosa remain 
unsolved due to their complex etiopathogenesis. Human papillomaviruses (HPVs), in particular, have 
been reported as the possible risk factors or cofactors. Th e aim of the study was to determine the 
 association of diﬀ erent HPV types with oral premalignant lesions, and the potential role of smoking 
and alcohol use. Eighty patients (mean age ± SD, 52.45±5.56) of both genders, 19 (23.75%) male and 
61 (76.25%) female, were enrolled in the study. Study group included 40 patients diagnosed with 
OPLs (leukoplakia, erythroplakia, actinic keratosis and lichen planus), while control group included 
another 40 patients with healthy oral mucosa. Genotyping of the HPV types was performed by 
 qualitative real-time HPV typing polymerase chain reaction test. HPV DNA was detected in 30% 
(12/40) of study group patients and 2.5% (1/40) of control group patients. Th e results revealed the 
presence of HPV16 in 15% (6/40), HPV56 in 10% (4/40), and HPV18 in 5% (2/40) of study group 
cases, and HPV31 in 1 (2.5%) control group patient. Th e association of oral HPV positivity and 
 smoking/alcohol use in the study group was not statistically signiﬁ cant (p>0.05). In conclusion, 
 high-risk HPV types are associated with oral premalignant disorders. However, it remains unknown 
whether HPV acts as an innocent bystander or it has a role in initiating development of premalignant 
lesions. Smoking and alcohol use were not associated with the existing oral HPV infection.
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Introduction
Oral premalignant lesions (OPLs) such as leuko-
plakia, erythroplakia and lichen planus have been 
strongly associated with alcohol and tobacco use, in-
creasing the risk of developing malignancy, although 
age, trauma and poor oral hygiene are pointed out as 
well1-3. In the last decades, researches emphasize the 
role of infective agents and of human papillomaviruses 
(HPV) in particular as the probable risk factors or co-
factors in the etiology of these entities. Th e possible 
association of OPLs and oral squamous cell cancer 
with HPV, as reported by Syrjänen et al.4, signiﬁ es the 
establishment of a new ﬁ eld of research. Th e role of 
HPV was additionally conﬁ rmed by verifying the 
presence of HPV in oropharyngeal cancers as well5. 
Regardless of diﬀ erent diagnostic methodology, stud-
ies pointed to the association of oral lesions and HPV 
infection. Previous studies report on 80% HPV posi-
tive leukoplakias6, and another study veriﬁ ed HPV 
DNA in 17.6% of oral leukoplakic lesions and 19.7% 
of oral lichen planus lesions7.
Even though it is considered that the group of oral 
cancers and oropharyngeal cancers are HPV associat-
ed, the role of HPV in oral cavity lesions requires fur-
ther interpretation and higher level of care8. Signiﬁ -
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cantly less often, HPV DNA is detected among to-
bacco smokers and/or chewers9, and no relationship of 
alcohol use and HPV positive or HPV negative cases 
has been detected10.
In order to estimate the role and association of dif-
ferent HPV types with OPLs, and the association of 
HPV infection with smoking and alcohol intake, we 
determined HPV presence by HPV DNA polymerase 




Th is case-control, clinical and molecular study was 
conducted at the Department of Periodontal Disease 
and Oral Pathology, St. Panteleimon University Den-
tal Clinic in Skopje, Republic of Macedonia. Eighty 
patients (mean age 52.45, range 39-61) of both gen-
ders, 19 (23.75%) male and 61 (76.25%) female, re-
ferred to the Department for diagnostic evaluation, 
were included in the study. Detailed history, medical 
history and clinical examination were performed in 
each patient. Forty patients diagnosed with OPLs, 
mean age 51.87±6.08, were included in the study 
group. Another randomly selected group of 40 pa-
tients, mean age 53.02±4.9, without visible changes of 
oral mucosa comprised the control group. Included 
subjects answered a questionnaire containing data on 
demographic features (age, gender, profession, habits, 
social conditions, smoking and alcohol use, etc.). All 
features of oral lesions were recorded, including clini-
cal diagnosis, topography and description. Each lesion 
was photographed as well.
All included subjects were verbally informed about 
the research and signed an informed consent form. Th e 
study was approved by the Educational and Scientiﬁ c 
Board of the Faculty of Dental Medicine, Skopje, Re-
public of Macedonia.
Molecular analysis
Molecular investigation was performed at the In-
stitute of Public Health, Skopje. Th e method of exfo-
liative brush cytology was used for sampling, detection 
and typing of HPV DNA. Smears were obtained from 
oral lesions in study group patients and from visually 
unchanged mucosa of the control group patients using 
a sterile brush (Kito-Brush, Italy). Th e mucosa was 
brushed as suggested by the manufacturer’s instruc-
tions and then a sterile cotton swab was used in addi-
tion. Both the brush and the cotton swab were placed 
in sterile 15-mL centrifuge tubes (ISOLAB, Laborg-
eräte GmbH, Wertheim, Germany) containing 1 mL 
of buﬀ ered saline solution with phosphate (PBS). Th e 
tubes were frozen within two hours at -20 °C until 
further processing.
Detection, screening and genotyping of HPV 
DNA from oral smears were done following the work-
ing protocol of the PureLincTM Genomic DNA Mini 
Kit (Invitrogen, USA). Consensus primers MY09/
MY11 amplifying a fragment from the L1region of the 
virus were used for HPV screening. Positive and nega-
tive controls were included for each reaction. Geno-
typing was performed by qualitative real-time HPV 
typing PCR test, HPV high risk genotyping multiplex 
real-time PCR test (Sacace Biotechnologies, I taly). 
Th e test allows for detection of the 12 most common 
high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 
56, 58 and 59). Th e test contains 4 diﬀ erent tubes, each 
containing primers for detection of speciﬁ c HPV 
types, as well as primers for ß-globin genes as internal 
control.
Descriptive statistics (with mean values and per-
centages) and Fisher’s exact test were used to process 
study results (Microsoft Excel Data Base and Statisti-
ca 7 software). Th e values of p<0.05 were considered 
statistically signiﬁ cant.
Results
Our study included 80 subjects of both genders, 
19/80 (23.75%) male and 61/80 (76.25%) female, di-
vided into two groups as follows: 40 patients diag-
nosed with OPLs as study group (mean age 51.87±6.08) 
and 40 randomly selected patients (mean age 53.02±
4.9) without visible changes of oral mucosa as control 
group. According to clinical examination and clinical 
diagnosis established by two experienced oral patholo-






Study group 12 30.00 28 70.00
Control group 1 2.50 39 97.50
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Table 2. HPV positivity in oral lesions and healthy mucosa











HPVneg 24/30.00 4/5.00 0/0.00 0/0.00 39/48.75 67/83.75
HPV56 4/5.00 0/0.00 0/0.00 0/0.00 0/0.00 4/5.00
HPV16 3/3.75 0/0.00 2/2.5 1/1.25 0/0.00 6/7.5
HPV18 0/0.00 0/0.00 2/2.5 0/0.00 0/0.00 2/2.5
HPV31 0/0.00 0/0.00 0/0.00 0/0.00 1/1.25 1/1.25
Total 31/38.75 4/5.00 4/5.00 1/1.25 40/50.00 80/100.00
Fig. 1. Distribution of HPV types in the study group.
Fig. 2. HPV positivity according to gender.
Table 3. Distribution of patients according to smoking and HPV positivity
Smoking










Yes 18/22.5 1/1.25 2/2.5 1/1.25 0/0.00 22/27.5
No 49/61.25 3/3.75 4/5.00 1/1.25 1/1.25 58/72.5
Total 67/93.50 4/2.00 6/3.00 2/1.00 1/0.50 80/100.00
gists, the OPLs and conditions detected were classi-
ﬁ ed as follows: lichen planus in 77.5% (31/40), leuko-
plakia in 10% (4/40), actinic (lip) keratosis in 10% 
(4/40) and erythroplakia in 2.5% (1/40) of patients11. 
Distribution of HPV positive and HPV negative cases 
is shown in Table 1. HPV DNA was detected in 30% 
(12/40) of study group patients and 2.5% (1/40) of 
control group patients (Table 1).
Distribution of diﬀ erent HPV types in the study 
group is illustrated in Figure 1. Th e results revealed the 
presence of HPV16 in 15% (6/40), HPV56 in 10% 
(4/40) and HPV18 in 5% (2/40) of patients, while 
70% (28/40) of cases were HPV negative.
Th e association of speciﬁ ed HPV types with cer-
tain clinical diagnosis in the study group and control 
group is shown in Table 2. All HPV positive cases had 
infection with single HPV type. Out of 80 patients in 
total, HPV56 was detected in 4 (5%) patients with li-
chen planus. HPV16 was detected in 6 (7.5%) patients, 
including 3 (3.75%) patients with lichen planus, 2 
(2.5%) patients with leukoplakia and one (1.25%) pa-
tient with erythroplakia. HPV18 was detected in 2 
(2.5%) patients with leukoplakia, and HPV31 in one 
(1.25%) control group patient with healthy mucosa. 
Based on the presented distribution of oral HPV posi-
tivity, Fisher’s exact test was statistically signiﬁ cant for 
positive and negative cases from both groups 
(p<0.0014). HPV56 was detected in 2 (2.5%) males, 
HPV16 in 2 (2.5%) males, and HPV18 in one (1.25%) 
patient. HPV56 was detected in 2 (2.5%) females, 
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HPV16 in 4 (5%) females, HPV18 (1.25%) in one fe-
male, and HPV31 in one (1.25%) female (Fig. 2). 
Fisher exact test yielded no statistically signiﬁ cant 
gender diﬀ erence in either positive or negative HPV 
cases (p<0.28).
Results on smoking and HPV positivity are shown 
in Table 3. Out of 22 (27.5%) smokers, HPV56 was 
detected in one (1.25%) patient, HPV16 in 2 (2.5%) 
patients, and HPV18 in one (1.25%) patient. Among 
nonsmokers (n=58, 72.5%), HPV56 was detected in 3 
(3.75%) patients, HPV16 in 4 (5%) patients, HPV18 
in one (1.25%) patient, and HPV31 also in one (1.25%) 
patient.
Distribution of HPV positivity with regard to alco-
hol use is illustrated in Table 4. Out of 5 (6.25%) pa-
tients that declared using alcohol drinks every day, one 
(1.25%) patient was positive for HPV16. Among pa-
tients that rarely used alcohol drinks (n=75, 93.75%), 
HPV56 positivity was detected in 4 (5%) patients, 
HPV16 in 5 (6.25%) patients, HPV18 in 2 (2.5%) pa-
tients and HPV31 in one (1.25%) patient. Oral HPV 
positivity was detected in only one (1.25%) patient 
that reported using alcohol drinks every day.
Discussion
Th e role of oral HPV infection in malignant altera-
tion of oral premalignant disorders remains unclear. 
Since a wide array of studies have evidenced and fairly 
highlighted the role of high-risk HPV in the etiology 
of oral cancers12, there are still disagreements about 
other oral lesions, especially concerning the premalig-
nant disorders and their association with HPV infec-
tion. Th e variability of diagnostic procedures used for 
detection and typing of HPV has resulted in great dif-
ferences in the interpretation of the incidence and role 
of HPV in the etiology of OPLs. Due to discrepancies 
among geographic areas and study populations regard-
ing particular HPV types13, interpreting and compar-
ing the results from diﬀ erent regions remains highly 
challenging.
In our study, HPV DNA was detected in 30% 
(12/40) of patients diagnosed with OPLs. In the group 
of patients with healthy mucosa, there was only 1/40 
(2.5%) HPV positive case (Table 1). All detected types, 
including the one from healthy mucosa, belonged to 
high-risk HPV types (Table 2). Th e results revealed 
the presence of HPV16 in 15% (6/40), HPV56 in 10% 
(4/40), and HPV18 in 5% (2/40) of study group pa-
tients (Fig. 1). All positive HPV cases were single 
HPV infections and we did not detect any case with 
multiple infection. HPV16 was detected in 7.5% 
(3/40) of cases with lichen planus, 5% (2/40) of cases 
with leukoplakia, and 2.5% (1/40) of cases with eryth-
roplakia. HPV18 was detected in 5% (2/40) of cases 
with leukoplakia and HPV56 in 10% (4/40) of cases 
with lichen planus. Our results are consistent with lit-
erature data disclosing HPV positivity in 17.8% of dif-
ferent oral lesions, premalignant and benign lesions, 
and 6.8% of HPV positive samples from healthy mu-
cosa as well, with a predominant prevalence of high-
risk HPV in potentially malignant disorders (HPV16 
and HPV31). Furthermore, the same study highlight-
ed the importance of topography, which is signiﬁ cant-
ly associated with HPV positivity of a particular lesion 
considering them as the “most frequently exposed 
sites” to microtrauma14. Findings reveal that HPV 
prevalence increases, being 10% in normal oral muco-
sa, 22% in benign leukoplakia, and reaching highest 
value of 46% in oral squamous cell carcinoma15.
We report on the presence of HPV16 and HPV18 
in OPLs, which is consistent with other studies of pre-
malignant and malignant lesions. Furthermore, we 
veriﬁ ed the presence of HPV56, which also belongs to 
high-risk HPV types, previously being evidenced in 
healthy mucosa as well16. Th ere are other study reports 
on the occurrence of the following genotypes in oral 
mucosa, in a decreasing order of frequency: 16, 6, 18, 
56 and 6617. So far, we could not ﬁ nd any research con-
Table 4. Alcohol users according to HPV positivity
Alcohol Oral HPV TotalHPVneg HPV56 HPV16 HPV18 HPV31 
Daily 4/5.00 0/0.00 1/1.25 0/0.00 0/0.00 5/6.25
Rarely 63/78.75 4/5.00 5/6.25 2/2.50 1/1.25 75/93.75
Total 67/83.75 4/5.00 6/7.50 2/2.50 1/1.25 80/100.00
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cerning the common association of HPV56 with oral 
lesions, in our case with lichen planus (10%), hence 
additional studies need to be done to evaluate its ap-
pearance and association with lichen planus, the site of 
appearance, or possibly with this geographic area. An-
other research reports only one HPV16 positive case 
(0.98%) in archived paraﬃ  n-embedded specimens18. 
Although most of the studies report that HPV18 is 
one of the most prevalent types in oral lesions, in our 
study it was detected in 5% of cases, and in another 
research it was not detected at all19.
Healthy mucosa is also exposed to HPV infection 
and the oral HPV predominance in macroscopically 
normal mucosa is very variable, although the reason 
has not yet been clariﬁ ed20. According to our results, 
the prevalence of HPV among healthy individuals is 
low (2.5%), which is in accordance with other stud-
ies21. Th e HPV31 detected in healthy mucosa belongs 
to high-risk HPV types, demonstrating that even 
healthy mucosa can be a carrier of high-risk HPV, 
therefore it is considered that poor oral health may in-
crease the susceptibility to and infectiousness of HPV 
as an additional risk factor 22.
Research data reveal that tobacco exposure and al-
cohol intake are signiﬁ cantly associated with prevalent 
oral HPV infection23,24. Th e association between HPV 
positivity and the critical risk factors for oral premalig-
nant and malignant diseases, smoking and alcohol in-
take, was not statistically signiﬁ cant (p>0.05) in this 
study, so HPV infection appears to be an independent 
manifestation considering these risk factors. However, 
smoking and alcohol might play an important role in 
creating proper environment for the acquisition or 
persistence of the virus, thus studies suggest that 
smoking may modify either the exposure to the 
HPV16 virus, the immune response to exposure, or 
both, but smoking itself does not enhance active infec-
tion25. Th is ﬁ nding was also conﬁ rmed by the results of 
this study.
Even though it remains unclear whether HPV 
positive OPLs are causally associated with the high-
risk HPV types detected or the virus is additionally 
‘nested’, the approach should be the same in view of 
the nature of the high-risk types.
Herewith, we conclude that high-risk HPV types 
are associated with oral premalignant disorders. How-
ever, it is still unknown whether HPV acts as an in-
nocent bystander, or it has a role in initiating develop-
ment of premalignant lesions. Smoking and alcohol 
use is not related to the existing oral HPV infection.
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Sažetak
HUMANI PAPILOMAVIRUS KAO POTENCIJALNI ČIMBENIK RIZIKA 
ZA ORALNE PREMALIGNE LEZIJE
L. Zendeli-Bedjeti, M. Popovska, A. Atanasovska-Stojanovska i S. Duvlis
Oralne premaligne lezije (OPL) kao i brojne promjene oralne sluznice ostaju neriješene zbog njihove složene etiopato-
geneze. Humani papilomavirusi (HPV) osobito su naglašeni kao mogući čimbenici i su-čimbenici rizika. Cilj ove studije bio 
je utvrditi udruženost različitih tipova HPV s OPL kao i potencijalnu ulogu pušenja i alkohola. U studiju je bilo uključeno 
80 pacijenata (srednja dob ± SD, 52,45±5,56 godina) obaju spolova: 19 (23,75%) muškaraca i 61 (76,25%) žena. Skupinu 
ispitanika s OPL činilo je 40 pacijenata s dijagnosticiranom OPL (leukoplakija, eritroplakija, aktinična keratoza i lihen 
 planus), dok je kontrolnu skupinu činilo 40 pacijenata sa zdravom oralnom sluznicom. Genotipizacija tipova HPV prove dena 
je kvalitativnim real-time PCR testom. HPV DNK je otkrivena u 30% (12/40) uzoraka ispitivane skupine pacijenata i 2,5% 
(1/40) uzoraka kontrolne skupine. Rezultati su pokazali prisutnost HPV16 kod 15% (6/40), HPV56 kod 10% (4/40) i 
HPV18 kod 5% (2/40) uzoraka skupine s OPL, a HPV31 u jednom (2,5%) uzorku kontrolne skupine. Udruženost pozitiv-
nih nalaza za oralni HPV i navika pušenja/alkohola u ispitivanoj skupini nije bila statistički značajna. U zaključku, visoko 
rizični tipovi HPV udruženi su s OPL, međutim, ostaje nepoznato djeluje li HPV kao nevini suputnik ili možda ima ulogu 
u razvoju tih lezija. Pušenje i alkohol nisu povezani s postojećom oralnom HPV infekcijom.
Ključne riječi: Oralne bolesti; Papillomaviridae; Humani papilomavirus 16; Lančana reakcija polimerazom; Makedonija
